Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study
Abstract
Clusterin, a glycoprotein implicated in Alzheimer’s disease (AD), remains unclear. The objective of this study was to analyze the effect of cerebrospinal fluid (CSF) clusterin in relation to AD biomarkers using a longitudinal cohort of non-demented individuals.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 24, 2023
- Source ID
- 10.3389/fnagi.2023.1256389
Entities
People
- Fan Guo
- Hao Wang
- Jia-yao Liu
- Lan Tan
- Ling-zhi Ma
- Wei Zhang
- Wei-yu Yuan
- Ze-hu Sheng
Organizations
- National Institutes of Health
- National Natural Science Foundation of China
- United States Department of Defense